Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 9, Number 1—January 2003

Research

Shiga Toxin–Producing Escherichia coli Infections Associated with Hemolytic Uremic Syndrome, Italy, 1988–2000

Alberto E. Tozzi*Comments to Author , Alfredo Caprioli*, Fabio Minelli*, Alessandra Gianviti†, Laura De Petris†, Alberto Edefonti‡, Giovanni Montini§, Alfonso Ferretti¶, Tommaso De Palo#, Maurizio Gaido**, Gianfranco Rizzoni‡, and the Hemolytic Uremic Syndrome Study Group
Author affiliations: *Istituto Superiore di Sanità, Rome, Italy; †Ospedale Pediatrico Bambino Gesù, Rome, Italy; ‡Pediatric Clinic “De Marchi,” Milan, Italy; §University of Padua, Padua, Italy; ¶Santobono Hospital, Naples, Italy; #Giovanni XXIII Hospital, Bari, Italy; **Regina Margherita Hospital, Turin, Italy.

Main Article

Figure

Distribution of hemolytic uremic syndrome cases associated with Shiga toxin–producing Escherichia coli O157, 026, O111, and O145, by year.

Figure. Distribution of hemolytic uremic syndrome cases associated with Shiga toxin–producing Escherichia coli O157, 026, O111, and O145, by year.

Main Article

1Members of the Hemolytic Uremic Syndrome Study Group are: A. Bettinelli, G. Capasso, A. Caringella, R. Coppo, G. Lama, S. Li Volti, S. Maffei, S. Maringhini, N. Miglietti, C. Pecoraro, I. Pela, M. Pennesi, R. Penza, L. Peratoner, F. Perfumo, I. Ratsche, E. Salvaggio, C. Setzu, and G. Zacchello.

TOP